Viewing Study NCT01436656

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:20 PM
Ignite Modification Date: 2026-05-27 @ 3:00 AM
Study NCT ID: NCT01436656
Status: COMPLETED
Last Update Posted: 2024-10-28
First Post: 2011-04-14
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Phase I Study of Oral LGX818 in Adult Patients With Advanced or Metastatic BRAF Mutant Melanoma
Sponsor: Pfizer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Melanoma and Metastatic Colorectal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRAF mutant, View
None BRAF mutated, View
None melanoma, View
None metastatic, View
None advanced, View
None RAF kinase inhibitor View
None BRAF V600 mutation View